| Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter … A Tucci, M Martelli, L Rigacci, P Riccomagno, MG Cabras, F Salvi, ... Leukemia & lymphoma 56 (4), 921-926, 2015 | 159 | 2015 |
| The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage … S Molica, TD Shanafelt, D Giannarelli, M Gentile, R Mirabelli, G Cutrona, ... American journal of hematology 91 (11), 1090-1095, 2016 | 87 | 2016 |
| Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC) SG Morano, R Latagliata, C Girmenia, F Massaro, P Berneschi, ... Supportive Care in Cancer 23, 3289-3295, 2015 | 64 | 2015 |
| Lack of intrafollicular memory CD4+ T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma P Mondello, A Fama, MC Larson, AL Feldman, JC Villasboas, ZZ Yang, ... Blood cancer journal 11 (7), 130, 2021 | 35 | 2021 |
| Texture analysis and multiple-instance learning for the classification of malignant lymphomas M Lippi, S Gianotti, A Fama, M Casali, E Barbolini, A Ferrari, F Fioroni, ... Computer methods and programs in biomedicine 185, 105153, 2020 | 33 | 2020 |
| Human pegivirus infection and lymphoma risk: A systematic review and meta-analysis A Fama, MC Larson, BK Link, TM Habermann, AL Feldman, TG Call, ... Clinical Infectious Diseases 71 (5), 1221-1228, 2020 | 30 | 2020 |
| New category of probable invasive pulmonary aspergillosis in haematological patients C Girmenia, P Guerrisi, AM Frustaci, A Fama, E Finolezzi, S Perrone, ... Clinical microbiology and infection 18 (10), 990-996, 2012 | 30 | 2012 |
| Italian Lymphoma Foundation (FIL). Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma … A Tucci, M Martelli, L Rigacci, P Riccomagno, MG Cabras, F Salvi, ... Leuk Lymphoma 56 (4), 921-926, 2015 | 28 | 2015 |
| Human Pegivirus infection and lymphoma risk and prognosis: a North American study A Fama, J Xiang, BK Link, C Allmer, D Klinzman, AL Feldman, ... British journal of haematology 182 (5), 644-653, 2018 | 26 | 2018 |
| Anagrelide treatment and cardiovascular monitoring in essential thrombocythemia. A prospective observational study G Tortorella, A Piccin, A Tieghi, L Marcheselli, M Steurer, G Gastl, ... Leukemia Research 39 (6), 592-598, 2015 | 25 | 2015 |
| A comparison of the conditioning regimens BEAM and FEAM for autologous hematopoietic stem cell transplantation in lymphoma: an observational study on 1038 patients from … J Olivieri, F Mosna, M Pelosini, A Fama, S Rattotti, M Giannoccaro, G Carli, ... Biology of Blood and Marrow Transplantation 24 (9), 1814-1822, 2018 | 23 | 2018 |
| Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin’s lymphoma C Pellegrini, A Broccoli, A Pulsoni, L Rigacci, C Patti, G Gini, D Mannina, ... Oncotarget 8 (53), 91703, 2017 | 23 | 2017 |
| Comparison of JAK2V617F‐positive essential thrombocythaemia and early primary myelofibrosis: The impact of mutation burden and histology R Latagliata, N Polverelli, A Tieghi, GA Palumbo, M Breccia, E Sabattini, ... Hematological Oncology 36 (1), 269-275, 2018 | 21 | 2018 |
| SFLT-1 levels in COVID-19 patients: Association with outcome and thrombosis. A Negro, A Fama, D Penna, L Belloni, A Zerbini, PG Giuri | 16 | 2021 |
| Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma A Broccoli, C Pellegrini, A Di Rocco, B Puccini, C Patti, G Gini, D Mannina, ... haematologica 102 (11), 1931, 2017 | 16 | 2017 |
| Vulnerable Elders Survey-13 (VES-13) predicts 1-year mortality risk in newly diagnosed non-Hodgkin lymphoma (NHL) A Fama, P Martin, C Allmer, C Casulo, JB Cohen, U Farooq, AL Feldman, ... Blood 134, 69, 2019 | 13 | 2019 |
| A gene expression–based model to predict metabolic response after two courses of ABVD in Hodgkin lymphoma patients S Luminari, B Donati, M Casali, R Valli, R Santi, B Puccini, S Kovalchuk, ... Clinical Cancer Research 26 (2), 373-383, 2020 | 12 | 2020 |
| Clinicopathologic characteristics, treatment, and outcomes of post-transplant lymphoproliferative disorders: a single-institution experience using 2017 WHO diagnostic criteria RL King, A Khurana, R Mwangi, A Fama, KM Ristow, MJ Maurer, ... Hemasphere 5 (10), e640, 2021 | 10 | 2021 |
| Intrafollicular CD4+ T-cells as an independent predictor of early clinical failure in newly diagnosed follicular lymphoma P Mondello, A Fama, MC Larson, ZZ Yang, JC Villasboas, AL Feldman, ... Blood 134, 121, 2019 | 10 | 2019 |
| Lenalidomide in Pretreated Patients with Diffuse Large B‐Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice A Broccoli, B Casadei, A Chiappella, C Visco, M Tani, N Cascavilla, ... The Oncologist 24 (9), 1246-1252, 2019 | 10 | 2019 |
